Literature DB >> 23810275

Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis.

Niels Teich1, Tobias Klugmann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23810275     DOI： 10.1016/j.crohns.2013.06.003

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  4 in total

1.  Failure of sublesional infliximab injection for refractory parastomal pyoderma gangrenosum in a patient with Crohn's disease.

Authors:  N Teich
Journal:  Tech Coloproctol       Date:  2014-06-26       Impact factor: 3.781

Review 2.  Pyoderma gangrenosum-a novel approach?

Authors:  Anastasia Atanasova Chokoeva; José Carlos Cardoso; Uwe Wollina; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2016-07-05

3.  The Cytokine TNF Promotes Transcription Factor SREBP Activity and Binding to Inflammatory Genes to Activate Macrophages and Limit Tissue Repair.

Authors:  Anthony Kusnadi; Sung Ho Park; Ruoxi Yuan; Tania Pannellini; Eugenia Giannopoulou; David Oliver; Theresa Lu; Kyung-Hyun Park-Min; Lionel B Ivashkiv
Journal:  Immunity       Date:  2019-07-11       Impact factor: 31.745

4.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.